Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Letter]. [PDF]
Drug Healthc Patient SafRahman NE.
europepmc +1 more source
Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama. [PDF]
Viruses, 2021 Rojas-Bonilla M +8 more
europepmc +1 more source
The epidemiology of non-polio enteroviruses: recent advances and outstanding questions [PDF]
, 2015 Grassly, N, Parker, E, Pons Salort, M
core +1 more source
Social technology and human health [PDF]
human development ...
David E. Bloom, River Path Associates and Karen Fang
core
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Response to Letter]. [PDF]
Drug Healthc Patient SafThomas F +7 more
europepmc +1 more source
[New oral polio vaccine: A turning point for the global polio eradication initiative?] [PDF]
Med Trop Sante Int, 2021 Bessaud M.
europepmc +1 more source
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone. [PDF]
Drug Healthc Patient SafThomas F +7 more
europepmc +1 more source
National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004-2019 demographic surveillance data in rural Bangladesh. [PDF]
EClinicalMedicine, 2021 Nielsen S +4 more
europepmc +1 more source